Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Dilated cardiomyopathy (mmu05414)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK043675
KLA  ATP  ATP+KLA
 AK043675 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830019B06 product:unclassifiable, full insert sequence. [AK043675] KLA 1.07 1.05 1.00 .98 1.05 1.02 1.00
ATP .92 1.07 .99 .93 1.01 1.01 1.02
KLA/ATP .96 .93 1.08 1.00 .94 .97 1.02
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actc1
KLA  ATP  ATP+KLA
 NM_009608 actin, alpha, cardiac (Actc1), mRNA [NM_009608] KLA 1.61 1.58 1.66 1.87 2.02 2.36 1.61
ATP 1.00 1.17 1.14 1.64 1.16 .90 1.01
KLA/ATP 1.67 1.82 1.77 2.58 1.70 1.43 1.33
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adrb1
KLA  ATP  ATP+KLA
 NM_007419 adrenergic receptor, beta 1 (Adrb1), mRNA [NM_007419] KLA .88 .86 .88 .86 .87 .87 .87
ATP .97 .97 .95 .89 .89 .90 .87
KLA/ATP .90 .88 .91 .84 .91 .79 .82
Atp2a2
KLA  ATP  ATP+KLA
 NM_001110140 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 1, mRNA [NM_001110140] KLA .95 1.07 .96 .84 1.17 1.16 1.53
ATP 1.16 1.27 .80 1.14 1.10 1.23 1.35
KLA/ATP 1.14 1.10 .54 1.15 .91 1.10 1.01
Atp2a2
KLA  ATP  ATP+KLA
 NM_009722 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 2, mRNA [NM_009722] KLA .90 .90 .99 .96 1.28 1.09 1.29
ATP 1.09 1.12 .94 1.19 1.47 1.36 .98
KLA/ATP .98 .95 .72 1.06 1.44 1.30 .88
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Cacna1f
KLA  ATP  ATP+KLA
 NM_019582 calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] KLA 1.03 .98 1.05 1.06 1.00 1.02 1.01
ATP 1.05 1.05 .95 .98 .97 .96 1.01
KLA/ATP 1.01 1.03 .94 1.01 1.01 1.00 .99
Cacna1s
KLA  ATP  ATP+KLA
 NM_001081023 calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] KLA 1.03 1.01 .96 1.06 1.00 1.00 1.05
ATP 1.01 .98 1.02 1.02 1.05 1.07 1.05
KLA/ATP .99 1.05 1.02 1.05 1.03 1.05 1.00
Cacna2d1
KLA  ATP  ATP+KLA
 AK046959 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930007O16 product:calcium channel, voltage-dependent, alpha2/delta subunit 1, full insert sequence. [AK046959] KLA 1.04 1.01 .94 .95 1.04 1.05 1.05
ATP 1.06 .98 .99 1.04 1.02 1.00 1.05
KLA/ATP 1.04 1.01 .99 1.04 .99 1.01 .99
Cacna2d1
KLA  ATP  ATP+KLA
 NM_009784 calcium channel, voltage-dependent, alpha2/delta subunit 1 (Cacna2d1), transcript variant e, mRNA [NM_009784] KLA 1.02 1.02 1.02 1.00 1.03 1.01 1.02
ATP .99 .97 1.07 1.01 .99 .97 1.00
KLA/ATP 1.03 .99 1.01 1.04 1.03 1.01 .92
Cacna2d2
KLA  ATP  ATP+KLA
 NM_020263 calcium channel, voltage-dependent, alpha 2/delta subunit 2 (Cacna2d2), mRNA [NM_020263] KLA 1.03 1.04 1.03 .99 1.03 .93 .93
ATP 1.01 1.06 1.06 1.15 1.03 .99 .93
KLA/ATP 1.04 1.01 1.10 1.13 1.11 .97 .89
Cacna2d3
KLA  ATP  ATP+KLA
 NM_009785 calcium channel, voltage-dependent, alpha2/delta subunit 3 (Cacna2d3), mRNA [NM_009785] KLA 1.00 .98 1.07 .96 .99 .99 .99
ATP .99 .97 1.10 .99 1.00 .89 .97
KLA/ATP .95 1.04 1.00 .95 1.02 .99 .98
Cacna2d4
KLA  ATP  ATP+KLA
 AK030723 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730412N02 product:hypothetical von Willebrand factor type A domain containing protein, full insert sequence. [AK030723] KLA .97 1.02 1.04 1.01 1.00 1.03 1.02
ATP 1.01 .93 1.03 1.01 .99 .99 1.01
KLA/ATP 1.03 .95 .87 .96 1.03 .97 1.05
Cacnb1
KLA  ATP  ATP+KLA
 NM_031173 calcium channel, voltage-dependent, beta 1 subunit (Cacnb1), transcript variant variant 1, mRNA [NM_031173] KLA 1.35 1.26 1.13 1.51 1.54 1.69 2.10
ATP 1.01 1.09 1.16 1.23 1.39 1.61 1.34
KLA/ATP 1.20 1.34 1.81 1.43 1.62 1.50 2.03
Cacnb2
KLA  ATP  ATP+KLA
 AK143332 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330008B16 product:calcium channel, voltage-dependent, beta 2 subunit, full insert sequence [AK143332] KLA 1.18 1.19 1.17 1.05 1.03 1.03 1.03
ATP .97 .91 1.02 1.07 .95 1.07 1.03
KLA/ATP 1.20 1.29 1.16 1.09 1.02 1.05 1.03
Cacnb2
KLA  ATP  ATP+KLA
 NM_023116 calcium channel, voltage-dependent, beta 2 subunit (Cacnb2), mRNA [NM_023116] KLA 1.23 1.15 1.47 1.25 1.02 1.02 1.05
ATP 1.00 1.01 .99 .99 1.02 1.01 1.01
KLA/ATP 1.21 1.27 1.12 1.24 .96 .98 1.02
Cacnb3
KLA  ATP  ATP+KLA
 NM_007581 calcium channel, voltage-dependent, beta 3 subunit (Cacnb3), transcript variant 1, mRNA [NM_007581] KLA 5.88 5.27 7.39 5.78 4.94 2.13 1.26
ATP 1.03 1.02 1.22 1.37 2.49 2.75 1.61
KLA/ATP 5.92 6.99 6.43 6.99 5.42 3.70 2.61
Cacnb4
KLA  ATP  ATP+KLA
 NM_001037099 calcium channel, voltage-dependent, beta 4 subunit (Cacnb4), transcript variant 1, mRNA [NM_001037099] KLA 1.07 1.11 1.17 1.11 1.15 1.13 1.07
ATP 1.00 1.00 1.03 1.06 1.21 1.17 1.50
KLA/ATP 1.13 1.12 1.15 1.16 1.35 1.69 1.32
Cacng1
KLA  ATP  ATP+KLA
 NM_007582 calcium channel, voltage-dependent, gamma subunit 1 (Cacng1), mRNA [NM_007582] KLA .98 .93 .99 .99 .96 .99 1.04
ATP 1.07 1.40 2.33 2.01 1.57 1.10 1.08
KLA/ATP 1.02 .94 .98 1.16 1.07 .98 1.05
Cacng2
KLA  ATP  ATP+KLA
 AK047238 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930041E13 product:hypothetical protein, full insert sequence [AK047238] KLA 1.18 1.18 1.12 1.11 1.10 1.17 1.35
ATP 1.03 .98 1.09 1.04 1.07 1.06 1.00
KLA/ATP 1.15 1.15 1.25 1.15 1.12 1.07 1.19
Cacng2
KLA  ATP  ATP+KLA
 NM_007583 calcium channel, voltage-dependent, gamma subunit 2 (Cacng2), mRNA [NM_007583] KLA 1.00 1.08 1.08 .95 1.07 1.09 1.03
ATP 1.04 1.05 1.05 1.04 1.00 1.02 .99
KLA/ATP 1.00 .98 1.02 1.09 1.06 1.07 1.03
Cacng3
KLA  ATP  ATP+KLA
 NM_019430 calcium channel, voltage-dependent, gamma subunit 3 (Cacng3), mRNA [NM_019430] KLA 1.07 1.09 1.00 .97 1.01 .94 .89
ATP 1.06 1.11 1.07 1.00 .98 .99 .97
KLA/ATP 1.07 1.06 1.03 .94 1.00 .99 .95
Cacng4
KLA  ATP  ATP+KLA
 AJ272045 mRNA for calcium channel gamma 4 subunit (CACNG4 gene) [AJ272045] KLA .99 .95 1.01 1.02 .98 1.09 .92
ATP .96 1.09 1.00 .95 .97 1.06 .95
KLA/ATP .97 1.01 1.04 .97 1.00 .96 .98
Cacng5
KLA  ATP  ATP+KLA
 NM_080644 calcium channel, voltage-dependent, gamma subunit 5 (Cacng5), mRNA [NM_080644] KLA .98 .99 .91 .98 1.02 .98 .98
ATP .96 1.02 .99 .99 1.05 1.04 .95
KLA/ATP .95 1.01 1.07 .99 1.02 .95 .99
Cacng6
KLA  ATP  ATP+KLA
 NM_133183 calcium channel, voltage-dependent, gamma subunit 6 (Cacng6), mRNA [NM_133183] KLA .95 .95 .94 1.03 .94 1.09 1.14
ATP 1.00 1.05 .95 1.05 .94 .93 .99
KLA/ATP 1.02 .98 .92 .97 1.02 .96 1.05
Cacng7
KLA  ATP  ATP+KLA
 NM_133189 calcium channel, voltage-dependent, gamma subunit 7 (Cacng7), mRNA [NM_133189] KLA 1.01 1.04 .98 1.01 1.00 1.05 1.02
ATP 1.05 1.03 .99 1.00 .98 .95 .98
KLA/ATP 1.00 .98 1.07 .99 .97 1.03 1.01
Cacng8
KLA  ATP  ATP+KLA
 NM_133190 calcium channel, voltage-dependent, gamma subunit 8 (Cacng8), mRNA [NM_133190] KLA 1.17 1.16 1.20 1.31 1.16 1.13 1.09
ATP .98 1.09 1.06 1.06 1.03 1.18 .99
KLA/ATP 1.27 1.35 1.29 1.09 1.04 1.06 1.19
Dag1
KLA  ATP  ATP+KLA
 NM_010017 dystroglycan 1 (Dag1), mRNA [NM_010017] KLA .74 .75 .67 .59 .62 .61 .66
ATP 1.16 1.24 .87 1.18 1.00 .91 1.17
KLA/ATP .88 .84 .53 .70 .75 .96 .90
Des
KLA  ATP  ATP+KLA
 NM_010043 desmin (Des), mRNA [NM_010043] KLA .99 1.01 1.01 1.02 1.02 1.03 1.01
ATP 1.00 1.00 1.01 1.02 .98 1.01 .99
KLA/ATP 1.02 1.02 1.10 1.01 1.00 1.01 1.01
Dmd
KLA  ATP  ATP+KLA
 AK044536 adult retina cDNA, RIKEN full-length enriched library, clone:A930019F21 product:DYSTROPHIN homolog [Mus musculus], full insert sequence. [AK044536] KLA 1.02 .99 .98 1.00 .94 1.06 1.02
ATP .94 1.06 .95 .96 1.00 1.00 1.02
KLA/ATP .98 1.07 1.01 .86 .96 1.02 1.04
Dmd
KLA  ATP  ATP+KLA
 NM_007868 dystrophin, muscular dystrophy (Dmd), mRNA [NM_007868] KLA 1.00 .99 1.00 1.02 1.02 1.00 1.03
ATP .99 1.03 1.02 1.03 1.00 1.01 1.00
KLA/ATP 1.03 1.03 1.01 1.01 1.03 1.04 .99
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Emd
KLA  ATP  ATP+KLA
 NM_007927 emerin (Emd), mRNA [NM_007927] KLA 1.03 1.19 .93 1.06 1.06 1.45 .93
ATP .98 1.14 .96 .91 .91 1.19 .69
KLA/ATP 1.07 1.17 1.08 1.13 1.07 1.07 1.04
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Igf1
KLA  ATP  ATP+KLA
 AK050118 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730016P09 product:unclassifiable, full insert sequence. [AK050118] KLA .13 .14 .15 .16 .22 .34 .48
ATP 1.78 2.05 1.37 .72 .34 .41 .58
KLA/ATP .24 .45 .50 .24 .20 .26 .68
Igf1
KLA  ATP  ATP+KLA
 NM_010512 insulin-like growth factor 1 (Igf1), transcript variant 1, mRNA [NM_010512] KLA .84 .78 .76 .67 .54 .48 .59
ATP .97 .98 1.13 1.13 1.03 .88 .89
KLA/ATP .82 .81 .93 .86 .83 .65 .89
Igf1
KLA  ATP  ATP+KLA
 NM_184052 insulin-like growth factor 1 (Igf1), transcript variant 2, mRNA [NM_184052] KLA .77 .82 .76 .65 .60 .52 .69
ATP 1.01 1.07 .98 1.06 1.03 .78 .94
KLA/ATP .89 .86 .77 .80 .75 .65 .89
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Itga1
KLA  ATP  ATP+KLA
 NM_001033228 integrin alpha 1 (Itga1), mRNA [NM_001033228] KLA 1.08 1.09 1.13 1.05 1.04 .99 1.01
ATP 1.02 .97 1.03 1.03 1.09 1.43 3.50
KLA/ATP 1.06 1.04 1.07 1.00 1.06 1.12 1.33
Itga10
KLA  ATP  ATP+KLA
 NM_001081053 integrin, alpha 10 (Itga10), mRNA [NM_001081053] KLA .98 1.00 1.00 1.04 1.04 .96 1.00
ATP 1.05 1.00 .97 .98 .95 .96 .97
KLA/ATP 1.04 .98 .92 .96 .95 .97 1.00
Itga11
KLA  ATP  ATP+KLA
 NM_176922 integrin, alpha 11 (Itga11), mRNA [NM_176922] KLA .95 .92 .90 .97 .93 .93 .96
ATP .97 .92 .98 .95 .90 .94 .95
KLA/ATP .86 .94 1.01 .93 .97 .94 .88
Itga2
KLA  ATP  ATP+KLA
 NM_008396 integrin alpha 2 (Itga2), mRNA [NM_008396] KLA 1.03 1.00 .98 1.01 .97 .96 1.00
ATP 1.05 .99 .93 1.02 1.04 1.03 .97
KLA/ATP .98 1.06 1.03 1.00 1.00 1.01 1.01
Itga2b
KLA  ATP  ATP+KLA
 NM_010575 integrin alpha 2b (Itga2b), mRNA [NM_010575] KLA 1.01 1.00 .98 1.04 1.01 1.04 1.18
ATP 1.01 .98 .95 1.02 .96 1.13 1.08
KLA/ATP 1.04 1.02 1.02 .95 1.05 1.53 1.23
Itga3
KLA  ATP  ATP+KLA
 NM_013565 integrin alpha 3 (Itga3), mRNA [NM_013565] KLA 1.06 1.09 1.10 1.17 1.19 1.29 1.41
ATP .99 .99 1.05 1.12 1.20 1.25 1.33
KLA/ATP 1.08 1.14 1.15 1.27 1.28 1.20 1.39
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itga5
KLA  ATP  ATP+KLA
 NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90
ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84
KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42
Itga6
KLA  ATP  ATP+KLA
 BC024571 integrin alpha 6, mRNA (cDNA clone IMAGE:5036677). [BC024571] KLA .44 .44 .37 .28 .25 .29 .34
ATP .96 1.01 .90 .58 .35 .11 .22
KLA/ATP .44 .41 .34 .23 .15 .09 .08
Itga6
KLA  ATP  ATP+KLA
 NM_008397 integrin alpha 6 (Itga6), mRNA [NM_008397] KLA .57 .58 .51 .45 .43 .44 .47
ATP 1.05 1.12 .86 .90 .57 .27 .36
KLA/ATP .64 .67 .50 .57 .39 .29 .26
Itga7
KLA  ATP  ATP+KLA
 L23423 gb|Mouse (BALB/c) alpha-7 integrin mRNA, complete cds. [L23423] KLA .96 1.03 1.00 1.07 1.02 1.07 1.14
ATP 1.00 1.00 1.04 1.88 2.09 1.34 1.16
KLA/ATP 1.04 .97 1.07 1.79 1.68 1.39 1.11
Itga7
KLA  ATP  ATP+KLA
 NM_008398 integrin alpha 7 (Itga7), mRNA [NM_008398] KLA .98 .95 .98 1.01 1.04 1.03 .98
ATP 1.00 1.02 1.06 1.75 1.92 1.20 1.02
KLA/ATP 1.03 1.07 1.06 1.48 1.58 1.23 1.05
Itga8
KLA  ATP  ATP+KLA
 NM_001001309 integrin alpha 8 (Itga8), mRNA [NM_001001309] KLA .80 .81 .79 .75 .63 .61 .44
ATP .98 1.04 1.06 .94 .79 .61 .50
KLA/ATP .79 .81 .81 .71 .70 .65 .48
Itgav
KLA  ATP  ATP+KLA
 AK052514 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430040G12 product:hypothetical protein, full insert sequence. [AK052514] KLA 1.04 .93 1.05 1.02 1.01 .93 1.03
ATP 1.05 1.04 1.13 1.12 1.12 .91 1.02
KLA/ATP 1.08 .97 1.02 .95 1.01 .96 1.05
Itgav
KLA  ATP  ATP+KLA
 AK171739 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008B15 product:unclassifiable, full insert sequence. [AK171739] KLA 1.04 .97 1.06 .95 1.15 .89 1.11
ATP 1.41 1.54 1.64 2.24 2.74 1.24 1.18
KLA/ATP 1.09 1.07 1.03 1.01 1.72 1.24 1.10
Itgav
KLA  ATP  ATP+KLA
 NM_008402 integrin alpha V (Itgav), mRNA [NM_008402] KLA 4.00 3.99 3.28 2.24 1.57 .95 1.13
ATP 1.14 1.22 1.13 1.39 2.22 2.47 1.70
KLA/ATP 4.59 4.61 2.48 2.44 1.60 1.88 2.56
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb3
KLA  ATP  ATP+KLA
 AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83
ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78
KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79
Itgb3
KLA  ATP  ATP+KLA
 NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15
ATP .94 .88 1.17 .89 .99 1.36 .91
KLA/ATP .51 .54 .67 .52 .61 .74 .48
Itgb4
KLA  ATP  ATP+KLA
 AK048888 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230078O20 product:integrin beta 4, full insert sequence. [AK048888] KLA .98 .92 .98 1.08 .97 1.02 1.02
ATP .99 .99 .91 1.03 1.02 1.00 1.05
KLA/ATP .99 1.03 .99 .98 .94 .98 1.01
Itgb4
KLA  ATP  ATP+KLA
 NM_001005608 integrin beta 4 (Itgb4), transcript variant 1, mRNA [NM_001005608] KLA 1.09 1.11 1.12 1.08 .98 .86 .85
ATP .90 .89 .90 .95 .87 .87 .84
KLA/ATP 1.06 1.08 1.10 1.18 1.07 .90 .76
Itgb5
KLA  ATP  ATP+KLA
 NM_010580 integrin beta 5 (Itgb5), mRNA [NM_010580] KLA .72 .68 .67 .66 .54 .43 .36
ATP 1.09 .94 .78 .57 .63 .56 .62
KLA/ATP .78 .64 .67 .51 .64 .67 .38
Itgb6
KLA  ATP  ATP+KLA
 NM_021359 integrin beta 6 (Itgb6), mRNA [NM_021359] KLA .97 1.02 1.04 1.06 1.06 1.04 1.01
ATP .99 1.00 1.01 .96 1.04 1.00 1.00
KLA/ATP .99 1.03 1.08 1.02 1.02 1.03 1.01
Itgb7
KLA  ATP  ATP+KLA
 NM_013566 integrin beta 7 (Itgb7), mRNA [NM_013566] KLA .91 .88 .93 1.19 .93 .76 .79
ATP 1.00 .96 1.30 1.44 2.84 3.07 7.90
KLA/ATP .96 1.05 1.35 1.20 2.70 3.53 8.17
Itgb8
KLA  ATP  ATP+KLA
 AK029281 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832412O06 product:SIMILAR TO INTEGRIN, BETA 8 homolog [Homo sapiens], full insert sequence. [AK029281] KLA 4.66 5.00 3.59 2.70 1.76 1.34 1.32
ATP 1.01 .98 1.09 1.16 2.15 5.24 1.17
KLA/ATP 5.59 6.39 4.38 1.99 1.84 2.55 2.11
Itgb8
KLA  ATP  ATP+KLA
 AK034644 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430018C17 product:integrin beta 8, full insert sequence. [AK034644] KLA 1.18 1.02 1.04 1.03 1.05 .94 .93
ATP .96 .97 .97 .96 .90 1.04 .99
KLA/ATP 1.06 1.06 1.15 .92 .99 1.00 1.09
Itgb8
KLA  ATP  ATP+KLA
 AK140969 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130086L01 product:hypothetical protein, full insert sequence [AK140969] KLA 3.63 3.76 4.16 3.31 2.72 1.58 1.40
ATP .98 1.01 1.31 1.14 1.28 6.11 1.65
KLA/ATP 3.84 4.18 3.75 2.83 1.92 3.44 4.81
Lama2
KLA  ATP  ATP+KLA
 AK046114 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230342M05 product:laminin, alpha 2, full insert sequence. [AK046114] KLA 1.06 1.00 .95 1.10 1.04 .99 .96
ATP .98 1.09 1.00 .97 .96 1.12 1.01
KLA/ATP .94 1.04 1.05 1.00 .99 1.00 .98
Lama2
KLA  ATP  ATP+KLA
 NM_008481 laminin, alpha 2 (Lama2), mRNA [NM_008481] KLA .96 .99 .96 1.02 .95 1.00 .97
ATP 1.05 1.00 1.01 .94 1.01 1.04 .96
KLA/ATP .99 1.04 1.06 1.10 .98 .95 .97
Lama2
KLA  ATP  ATP+KLA
 U12147 laminin-2 alpha2 chain mRNA, complete cds. [U12147] KLA .96 1.00 .99 1.00 .98 1.02 1.03
ATP 1.01 .99 1.02 1.04 1.01 .99 1.02
KLA/ATP 1.00 1.01 1.00 1.01 .99 1.04 1.00
Lmna
KLA  ATP  ATP+KLA
 NM_019390 lamin A (Lmna), transcript variant 2, mRNA [NM_019390] KLA .86 .86 .78 .66 .47 .27 .37
ATP .99 1.01 1.03 1.23 1.27 1.13 1.61
KLA/ATP .89 .86 .80 .86 .99 .86 1.14
Mm.21499
4
KLA  ATP  ATP+KLA
 148540002 Unknown KLA 1.04 1.08 1.14 1.05 1.07 1.18 1.23
ATP 1.02 .99 1.08 1.05 1.00 1.01 1.01
KLA/ATP 1.02 1.11 1.10 .99 1.03 1.10 1.11
Mm.29512
4
KLA  ATP  ATP+KLA
 47894397 Unknown KLA 2.28 2.33 2.46 2.01 2.46 1.89 .67
ATP 1.01 1.07 .89 .84 .86 1.54 .78
KLA/ATP 2.15 2.39 1.74 1.93 1.46 1.24 .66
Mm.35799
0
KLA  ATP  ATP+KLA
 21687185 Unknown KLA 1.18 1.20 1.19 1.23 1.18 1.19 1.10
ATP .97 1.07 1.11 1.19 1.01 1.15 .98
KLA/ATP 1.06 1.29 1.19 1.29 1.19 1.10 1.10
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44077
3
KLA  ATP  ATP+KLA
 124517717 Unknown KLA .69 .69 .71 .76 .71 .73 .58
ATP .93 .96 1.01 .85 .73 .76 .57
KLA/ATP .60 .65 .75 .80 .76 .66 .55
Mm.44591
2
KLA  ATP  ATP+KLA
 9506452 Unknown KLA .98 .99 1.00 1.07 .99 .98 1.07
ATP 1.02 1.05 .94 .96 1.01 1.00 .94
KLA/ATP 1.01 1.08 1.04 .92 .92 1.00 1.03
Mm.45798
3
KLA  ATP  ATP+KLA
 118131045 Unknown KLA .95 1.08 1.17 1.13 1.10 1.13 1.06
ATP 1.02 .97 1.03 1.07 1.17 1.22 1.05
KLA/ATP 1.04 1.05 1.06 1.11 1.41 1.49 1.08
Mm.46359
0
KLA  ATP  ATP+KLA
 21687181 Unknown KLA .76 .80 .87 .99 .94 1.02 .98
ATP .90 .94 1.06 .97 .83 .93 .85
KLA/ATP .79 .91 .98 1.01 .97 .84 .78
Mm.87663
KLA  ATP  ATP+KLA
 142370454 Unknown KLA 1.04 1.01 1.01 1.10 .95 1.04 .95
ATP .96 1.01 .96 .98 .94 1.05 1.12
KLA/ATP .98 .97 1.12 1.03 1.06 .94 1.02
Mybpc3
KLA  ATP  ATP+KLA
 NM_008653 myosin binding protein C, cardiac (Mybpc3), mRNA [NM_008653] KLA 11.37 10.79 7.68 7.40 7.29 5.85 3.02
ATP 1.06 .76 .98 10.87 12.21 5.59 1.01
KLA/ATP 13.19 8.47 5.73 8.17 37.83 6.64 3.87
Myh6
KLA  ATP  ATP+KLA
 NM_010856 myosin, heavy polypeptide 6, cardiac muscle, alpha (Myh6), mRNA [NM_010856] KLA 1.00 1.01 1.00 .99 1.00 .98 1.02
ATP 1.00 .99 .96 .98 1.01 1.01 .98
KLA/ATP 1.03 1.04 1.01 1.01 .99 1.00 1.02
Myh7
KLA  ATP  ATP+KLA
 NM_080728 myosin, heavy polypeptide 7, cardiac muscle, beta (Myh7), mRNA [NM_080728] KLA 1.06 1.13 1.14 1.07 1.09 1.06 1.03
ATP .96 1.01 1.09 1.05 1.15 1.16 1.12
KLA/ATP 1.01 1.05 1.02 .98 1.29 1.62 1.09
Myl2
KLA  ATP  ATP+KLA
 NM_010861 myosin, light polypeptide 2, regulatory, cardiac, slow (Myl2), mRNA [NM_010861] KLA .88 .93 .94 .95 .94 .77 .60
ATP .96 1.04 1.14 1.06 1.00 .93 .66
KLA/ATP .91 .85 1.07 1.03 .88 .79 .67
Myl3
KLA  ATP  ATP+KLA
 NM_010859 myosin, light polypeptide 3 (Myl3), mRNA [NM_010859] KLA 1.08 1.10 1.14 1.11 1.15 1.25 1.14
ATP 1.00 1.08 1.19 1.24 1.17 1.16 1.03
KLA/ATP 1.16 1.17 1.18 1.28 1.21 1.23 1.14
Pln
KLA  ATP  ATP+KLA
 NM_023129 phospholamban (Pln), mRNA [NM_023129] KLA 1.01 1.03 1.07 1.02 1.01 1.01 .97
ATP 1.02 1.00 .91 1.00 .98 .99 .98
KLA/ATP 1.01 1.07 1.08 .93 .99 1.01 .95
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ryr2
KLA  ATP  ATP+KLA
 BC043140 ryanodine receptor 2, cardiac, mRNA (cDNA clone IMAGE:6822493), complete cds. [BC043140] KLA .97 1.03 1.01 1.03 1.03 1.01 1.05
ATP .99 .98 1.03 1.02 1.01 1.09 1.04
KLA/ATP .98 1.00 .98 1.04 1.04 1.06 1.00
Ryr2
KLA  ATP  ATP+KLA
 NM_023868 ryanodine receptor 2, cardiac (Ryr2), mRNA [NM_023868] KLA 1.04 1.02 1.00 1.00 1.03 .97 .96
ATP .95 1.04 1.00 .94 .98 1.01 1.08
KLA/ATP .99 .97 1.02 1.03 1.00 .98 1.00
Sgca
KLA  ATP  ATP+KLA
 NM_009161 sarcoglycan, alpha (dystrophin-associated glycoprotein) (Sgca), mRNA [NM_009161] KLA .96 1.06 1.08 1.01 1.06 1.10 1.08
ATP 1.00 .99 1.04 1.04 1.06 .90 1.05
KLA/ATP .98 .96 1.06 1.03 1.18 1.17 1.11
Sgcb
KLA  ATP  ATP+KLA
 AK009080 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310001O14 product:unclassifiable, full insert sequence. [AK009080] KLA 1.32 1.24 1.20 1.23 1.10 1.06 .97
ATP .93 .85 .88 .89 .94 .93 1.01
KLA/ATP 1.19 1.13 .98 .92 1.03 1.04 .97
Sgcb
KLA  ATP  ATP+KLA
 NM_011890 sarcoglycan, beta (dystrophin-associated glycoprotein) (Sgcb), mRNA [NM_011890] KLA 2.98 2.85 3.65 3.67 3.43 2.59 1.47
ATP 1.15 1.07 1.28 1.20 1.19 1.03 1.42
KLA/ATP 2.87 3.08 3.92 3.05 2.71 2.38 1.91
Sgcd
KLA  ATP  ATP+KLA
 NM_011891 sarcoglycan, delta (dystrophin-associated glycoprotein) (Sgcd), mRNA [NM_011891] KLA 1.08 1.07 1.01 1.01 1.07 .96 .93
ATP 1.00 .95 1.03 1.08 1.00 .98 1.01
KLA/ATP .97 .97 1.08 1.03 .95 1.01 1.03
Sgcg
KLA  ATP  ATP+KLA
 NM_011892 sarcoglycan, gamma (dystrophin-associated glycoprotein) (Sgcg), mRNA [NM_011892] KLA .94 .94 1.05 1.06 1.00 1.02 .98
ATP 1.02 .98 1.19 1.08 1.10 1.14 .90
KLA/ATP 1.02 1.06 1.09 1.22 1.13 1.08 .82
Slc8a1
KLA  ATP  ATP+KLA
 AF004666 sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] KLA 1.13 1.10 1.22 1.44 1.52 1.55 1.10
ATP 1.03 1.05 1.22 1.12 .65 .49 .67
KLA/ATP 1.04 1.21 1.30 1.44 .81 .63 1.01
Slc8a1
KLA  ATP  ATP+KLA
 AF108396 sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] KLA 1.07 1.18 1.30 1.22 1.31 1.39 1.21
ATP 1.03 1.02 1.10 1.07 .88 .91 1.23
KLA/ATP 1.15 1.17 1.14 1.22 .96 1.01 1.77
Slc8a1
KLA  ATP  ATP+KLA
 NM_011406 solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] KLA 1.12 1.16 1.22 1.25 1.35 1.33 1.11
ATP 1.03 1.04 1.07 1.10 .93 .90 1.19
KLA/ATP 1.13 1.24 1.19 1.16 .93 1.06 1.62
Tgfb1
KLA  ATP  ATP+KLA
 NM_011577 transforming growth factor, beta 1 (Tgfb1), mRNA [NM_011577] KLA .87 .89 .90 .70 .83 .77 1.12
ATP 1.20 1.41 .80 1.49 1.11 .93 .99
KLA/ATP 1.10 1.20 .53 1.05 .66 .85 .90
Tgfb2
KLA  ATP  ATP+KLA
 NM_009367 transforming growth factor, beta 2 (Tgfb2), mRNA [NM_009367] KLA 1.01 .91 .98 .98 .92 1.19 .96
ATP .99 1.03 1.00 1.02 .99 1.07 .93
KLA/ATP 1.02 .99 1.03 .98 1.04 1.06 .96
Tgfb3
KLA  ATP  ATP+KLA
 NM_009368 transforming growth factor, beta 3 (Tgfb3), mRNA [NM_009368] KLA .67 .64 .58 .56 .49 .52 .61
ATP .90 .92 1.33 1.08 .78 .65 .74
KLA/ATP .58 .60 .74 .61 .76 1.36 1.51
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnnc1
KLA  ATP  ATP+KLA
 NM_009393 troponin C, cardiac/slow skeletal (Tnnc1), mRNA [NM_009393] KLA .52 .57 .60 .71 .91 1.03 1.71
ATP .92 .70 .67 .76 1.70 1.56 4.25
KLA/ATP .57 .55 .60 .66 1.03 .86 2.98
Tnni3
KLA  ATP  ATP+KLA
 NM_009406 troponin I, cardiac (Tnni3), mRNA [NM_009406] KLA 2.51 2.58 2.65 2.15 2.99 3.24 2.22
ATP 1.06 1.04 1.00 1.06 .69 .91 .68
KLA/ATP 2.78 2.94 2.75 2.10 1.22 1.46 1.67
Tnnt2
KLA  ATP  ATP+KLA
 AK086260 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930016O21 product:troponin T2, cardiac, full insert sequence [AK086260] KLA 1.03 1.00 .97 .99 1.01 .96 1.01
ATP .97 1.08 .91 .97 .96 1.10 1.03
KLA/ATP .99 1.01 1.07 .97 1.00 1.01 1.09
Tnnt2
KLA  ATP  ATP+KLA
 NM_011619 troponin T2, cardiac (Tnnt2), mRNA [NM_011619] KLA 1.01 1.03 1.05 1.07 1.04 1.00 .99
ATP .97 .97 1.04 1.07 .96 .99 1.06
KLA/ATP 1.11 1.12 1.04 1.03 .98 1.02 1.04
Tpm1
KLA  ATP  ATP+KLA
 NM_024427 tropomyosin 1, alpha (Tpm1), mRNA [NM_024427] KLA .89 .89 .84 .57 .52 .63 .73
ATP 1.01 1.03 1.00 1.10 1.86 1.03 1.48
KLA/ATP .96 .89 .81 .76 1.00 .89 1.11
Tpm2
KLA  ATP  ATP+KLA
 NM_009416 tropomyosin 2, beta (Tpm2), mRNA [NM_009416] KLA .97 1.09 .97 .96 1.01 1.05 .86
ATP 1.04 1.02 1.09 1.12 1.04 .98 .83
KLA/ATP 1.07 1.15 1.10 1.16 1.06 .90 .83
Tpm3
KLA  ATP  ATP+KLA
 NM_022314 tropomyosin 3, gamma (Tpm3), mRNA [NM_022314] KLA 1.24 1.34 1.32 1.37 1.58 1.38 1.21
ATP 1.11 1.25 .97 1.43 1.09 .80 1.10
KLA/ATP 1.43 1.65 1.10 1.73 1.02 1.06 1.55
Tpm4
KLA  ATP  ATP+KLA
 NM_001001491 tropomyosin 4 (Tpm4), mRNA [NM_001001491] KLA 2.08 2.02 2.44 2.21 2.15 1.91 .69
ATP 1.03 .97 .97 .84 .97 1.75 .77
KLA/ATP 2.12 2.08 2.20 1.78 1.71 1.33 .69
Ttn
KLA  ATP  ATP+KLA
 AK010153 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310074I15 product:similar to NOVEX-3 TITIN ISOFORM [Homo sapiens], full insert sequence [AK010153] KLA 1.14 1.20 1.25 1.25 1.08 1.17 1.03
ATP 1.02 1.05 1.02 1.10 .95 .95 .99
KLA/ATP 1.26 1.27 1.09 1.20 1.08 1.24 .98
Ttn
KLA  ATP  ATP+KLA
 NM_011652 titin (Ttn), transcript variant N2-A, mRNA [NM_011652] KLA .95 .98 .99 .99 1.01 1.00 1.04
ATP 1.03 .99 1.05 1.01 .99 1.01 1.07
KLA/ATP 1.02 1.03 .95 1.06 1.04 1.08 1.04